And numerous studies also showed PROTAC drugs are more efficient than the original antagonist.[25] MOLM‐13 is an acute myeloid leukemia cell line that overexpresses wild‐type p53 and MDM2 but lacks the Philadelphia chromosome. This evidence concerns the gene MDM2 and acute myeloid leukemia.